All News

Russell Brewer, DrPH, a research associate professor at University of Chicago Medicine, discusses the lessons from both the HIV epidemic and the COVID-19 pandemic in regard to how health systems can more effectively address health care disparities in BIPOC communities.

Russell Brewer, DrPH, a research associate professor at University of Chicago Medicine, and P.J. Moton-Poole, a senior manager at ViiV Healthcare, discuss the expansion of the accelerate initiative, which funds projects that support the health and wellbeing of Black same-gender-loving men throughout the United States.

OTC Product News from PT Retail March 2021.

The APhA and the CDC announced that they have entered into a collaborative agreement focused on supporting the role of pharmacists in building the public’s confidence in COVID-19 vaccines.

The studies had a minimum follow-up period of 24 weeks and reported at least 1 event of breast cancer or benign breast neoplasm, which included 90,360 participants.

The researchers used cross-sectional surveys, which were conducted with a convenience sample of rural community pharmacists who were part of a rural community pharmacy practice-based research network.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Daily national surveys by Carnegie Mellon University (CMU) show that although COVID-19 vaccine uptake has increased, the proportion of vaccine-hesitant adults has remained unchanged.

In a clinical trial of idecabtagene vicleucel in multiple myeloma, the overall response rate for the efficacy evaluable population was 72%, and 28% of participants achieved a stringent complete response.

Investigators may have found a way to locate chemicals capable of suppressing HIV into its dormant state.

Through investigating a type of toxin released by the most dangerous strains of C. diff, researchers now have a map for developing drugs that can block the toxin and prevent the bacteria from entering human cells.

The analysis found that more than twice as many women who received olaparib were still alive 5 years after the beginning of the study with no progression of their cancer.

The pharmacy community has stepped up mightily to ensure this massive health care effort is successful.

Mitchell Horwitz, MD, principal investigator and professor of medicine at the Duke Cancer Institute, discusses the results of a phase 3 study of omidubicel, which treats patients with hematologic malignancies in need of a bone marrow.

A prognostic COVID-19 Severity Test has been launched for the identification of high-risk individuals who are likely to experience the most severe COVID-19 complications upon exposure to the virus.

In an interview with Pharmacy Times, Sandra Leal, PharmD, MPH, FAPhA, CDE, said pharmacists along the United States-Mexico border must consider the unique needs of their patients, including those with language barriers or those in underserved populations.

The STEP1 study included 1961 adults with a body mass index (BMI) of 27 or higher with at least 1 weight-related health condition, or a BMI of 30 or higher, without diabetes.

Researchers found no evidence that protection against COVID-19 reinfection declined within a 6-month follow-up period.

Although childbirth remains a difficult, often stressful experience for mothers, the advent of opioid medications for labor pain relief and the use of appropriate sanitation methods has made childbirth far safer for mothers than was possible during previous periods in history.

In addition to cardiotoxicity from cancer-related treatments, the researchers noted that obesity, cancer, and cardiovascular disease share some common risk factors.

As the pandemic has continued, it has helped shine a light on how important pharmacists, pharmacy interns, and pharmacy technicians can help impact their communities.

Advice for clinical pharmacists who help manage patients with relapsed/refractory multiple myeloma in the current era of novel therapies and recommendations to improve upon current practice patterns.

Novel treatment strategies being explored in clinical trials that look exciting in relapsed/refractory multiple myeloma, and implications for using these newer approaches in the future.

The importance of coordinated care and proper education to pharmacists on best practices when dispensing anti-BMCA therapy to patients with relapsed/refractory multiple myeloma.

Pharmacy Times spoke with Josh Benner, pharmacist and CEO/founder of RxAnte, about medication misuse and the future of pharmacy in 2021.

Digital health products and solutions expand ways to guide prevention and treatment.

DKN-01 is a humanized monoclonal antibody that binds to and blocks the activity of the Dickkopf-1 (DKK1) protein, which activates the innate immune system in the tumor microenvironment and anti-tumor activity.

Caroline Carney, MD, MSc, FAPM, CPHQ, CMO of Magellan Health, discusses how pharmacists and other medical professionals can boost their brain health and keep a positive mindset while working during the pandemic.

Although ART has helped improve the health of those with HIV, they are at a greater risk of developing complications related to chronic inflammation, such as cardiovascular disease.

The plot clinical trial included 40 men and is believed to be the first published study to use progesterone to treat male COVID-19 patients whose lung functions have been compromised by the virus.